Lb Pharmaceuticals LBRX
NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST

Lb Pharmaceuticals (LBRX) Operating Leases (2024 - 2026)

Updated

Lb Pharmaceuticals' Operating Leases came in at $4.37 million for Q2 2026, up 59.6% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals' Operating Leases was $2.84 million, down 11.7% from FY2024.

  • Going back by year, Operating Leases was $3.22 million in FY2024.
  • Business Quant data shows LBRX's Operating Leases at $2.74 million (Q1 2026), $2.84 million (Q4 2025) and $2.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Lb Pharmaceuticals 1.45 Bn 410.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.20 Mn
Jun 30, 2026 4.37 Mn
Mar 31, 2026 2.74 Mn
Dec 31, 2025 2.84 Mn
Sep 30, 2025 2.94 Mn
Dec 31, 2024 3.22 Mn
API Access

Lb Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=LBRX&period=max&api_key=YOUR_API_KEY